The purpose of the present study was to dynamically analyze the role of antiphospholipid syndrome in patients with acute disturbances of cerebral blood flow. Twenty-eight patients (16 females and 12 males) aged between 47 and 61 years were examined. The following criteria for patient's incorporation into the study were observed: presence of a focal neurological deficit, ultrasonographic evidence of disturbed cerebral blood flow, CT or MRI data about brain stroke. According to the data from the clinical or x-ray examination, the patients were divided into three groups: with hemorrhagic, embolic, or thrombotic stroke. Anticardiolipid (aCL) antibodies were assessed by ELISA method for a 12-month period. Elevated titres of aCL antibodies were proved in 12 patients (in 43 per cent of the cases) - in ten with ischemic and in two - with hemorrhagic stroke. The treatment with neuroprotective, antiaggregation and immunomodulatory means resulted in improvement of the clinical symptoms and antiphospholipid syndrome as well. It could be concluded that the summarized clinical, roentgenological and immunological data suggest the involvement of elevated titres of aCL antibodies into the pathogenesis of the acute cerebral blood flow disorders. The estimation of these antibodies should be considered obligatory in the patients with stroke with a view to enlargement of the prognostic criteria and more adequate therapeutic approach.
Antiphospholipid Antibodies in Stroke Study Group (APASS).- Stroke, 21, 1990, 1268-1273.
Brannagan, T. H., K. J. Nagle , D. J. Lange, L. P. Rowland . Complications of intravenous immunoglobulin treatment in neurologic disease.- Neurology, 47, 1997, No 3, 899-900.
Elkayam, O ., D. Paran, R. Milo, Y. Davidovitz , D. A lmoznino-Sarafian, D. Zelster, M. Yaron, D. Caspi. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.- Arm. Rheum. Dis., 59, 2000, No 1, 77-80.
Hess, D. Stroke associated with antiphospholipid antibodies.- Stroke, 23, 1992, Suppl., 123-128.
Koike, T. Antiphospholipid antibodies in arterial thrombosis.- Ann. Med., 32, 2000, Suppl. 1, 27-31.
Marai, I., Y. Levi, G. Godard, Y. Shoenfeld. Following 90 patients with APLS with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population.- Harefuah, 140, 2001, No 6, 495-500; 565.
Petri, M. Diagnosis of antiphospholipid antibodies.- Rheum. Dis. Clin. North Am., 20, 1994, 443-469.
Rademacher, J ., D. Sohngen, C. Specker, J. Janda, M. Sitzer. Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the APLS of systemic lupus erythematosus.- Acta Neurol. Scand., 99, 1999, No 6, 351-361.
Sherer, Y., Y. Levy, Y. Shoenfeld. Intravenous immunoglobulin therapy of antiphospholipid syndrome.- Rheumatology (Oxford), 39, 2000, No 4, 421-426.
Specker, C ., J. Rademacher, D. Sohngen, M. Sitzer , J. Janda, M. Siebler, H. Steinmetz, M. Schneider. Cerebral microemboli in patients with antiphospholipid syndrome.- Lupus, 6, 1997, No 8, 638-644.
Wiener, M. H., M. Burke , M. Friend , I. Yust. Thromboagglutination by anticardiolipin antibody complex in the antiphospholipid syndrome, a possible mechanism of immunomediated thrombosis.- Thrombos. Res, 103, 2001, No 3, 193-199.
Email this article (Login required) 
